Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (TheStreet) -- STOCK COMMENTS / EPS CHANGES
Apple (AAPL) estimates, target increased at Citigroup. Shares of AAPL now seen reaching $450. Estimates also raised on stronger than expected iPhone demand. Buy rating.Apple (AAPL) estimates raised at UBS through 2012. Strong iPad2 sales and higher gross margins. Maintain $510 price target and Buy rating. Amgen (AMGN) estimates, target changed at UBS. Shares of AMGN now seen reaching $58. Estimates were increased on potential Prolia acceleration. Neutral rating. Campbell Soup (CPB) estimates changed at UBS. CPB estimates were raised through 2011, but lowered for 2012. Company has positive recovery plan, but ongoing negative volume trends. $36 price target and Neutral rating. Diodes (DIOD) estimates, target lowered at UBS. Shares of DIOD now seen reaching $27, according to UBS. Estimates also lowered on limited potential for near term margin expansion. Neutral rating. Electronic Arts (ERTS) estimates upped at BMO through 2013. Company increased its guidance. Outperform rating and $28 price target. Electronic Arts (ERTS) estimates, target raised at UBS. Shares of ERTS now seen reaching $27, according to UBS. Estimates also raised, as company acquires casual game development studio PopCap . Buy rating. Fastenal (FAST) estimates, target boosted at Credit Suisse. Shares of FAST now seen reaching $39, according to Credit Suisse. Estimates also upped, given improving business momentum. Neutral rating. Gilead Sciences (GILD) estimates lowered at UBS through 2012. Updated model reflects prescription trends and pricing changes. Maintain $47 price target and Buy rating.
Infosys (INFY) estimates increased at Oppenheimer through 2013. Industry demand trends should remain strong. Perform rating. KAR Auction (KAR) target raised at Goldman. Shares of KAR now seen reaching $18. Salvage business is improving. Neutral rating. LAM Research (LRCX) estimates, target cut at UBS. Shares of LRCX now seen reaching $55. Estimates also lowered to reflect more conservative near term trends. Maintain Buy rating. Nasdaq OMX (NDAQ) estimates, target cut at Jefferies. Shares of NDAQ now seen reaching $27. Estimates also lowered as near term M&A activity appears unlikely. Maintain Hold rating.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV